131 related articles for article (PubMed ID: 4628155)
1. Plasma fractionation methods used in Sweden.
Björling H
Vox Sang; 1972; 23(1):18-25. PubMed ID: 4628155
[No Abstract] [Full Text] [Related]
2. The current status of blood fractionation in the United States.
Sgouris JT
Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
[No Abstract] [Full Text] [Related]
3. Fractionation of plasma with polyethylene glycol.
Polson A; Ruiz-Bravo C
Vox Sang; 1972; 23(1):107-18. PubMed ID: 5081005
[No Abstract] [Full Text] [Related]
4. Plasma fractionation in England and Wales.
Vallet L
Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157
[No Abstract] [Full Text] [Related]
5. Precipitation methods in plasma fractionation.
Steinbuch M
Vox Sang; 1972; 23(1):92-106. PubMed ID: 5081018
[No Abstract] [Full Text] [Related]
6. Preparation of Australia antigen free human albumin with polyethylene glycol.
Polson A; Parker JR
Prep Biochem; 1973; 3(1):31-45. PubMed ID: 4725231
[No Abstract] [Full Text] [Related]
7. The development of plasma derivatives for clinical use. A symposium summary.
Deutsch HF
Vox Sang; 1972; 23(1):147-50. PubMed ID: 5081010
[No Abstract] [Full Text] [Related]
8. Notes on the production of plasma derivatives in France.
Steinbuch M
Vox Sang; 1972; 23(1):56-7. PubMed ID: 4117049
[No Abstract] [Full Text] [Related]
9. The fate of austrialia antigen during plasma fractionation.
Geiger H; Kranz Th; Haupt H
Dev Biol Stand; 1974; 27():158-65. PubMed ID: 4477984
[No Abstract] [Full Text] [Related]
10. The development of plasma derivatives in Canada.
McVicar GA
Vox Sang; 1972; 23(1):33-4. PubMed ID: 4117046
[No Abstract] [Full Text] [Related]
11. Isolation of albumin from whole human plasma and fractionation of albumin-depleted plasma.
Travis J; Bowen J; Tewksbury D; Johnson D; Pannell R
Biochem J; 1976 Aug; 157(2):301-6. PubMed ID: 962868
[TBL] [Abstract][Full Text] [Related]
12. Blood fractionation: proteins.
Stryker MH; Bertolini MJ; Hao YL
Adv Biotechnol Processes; 1985; 4():275-336. PubMed ID: 3902053
[No Abstract] [Full Text] [Related]
13. [Australia antigen in human plasma fractionation products].
Leveque P; North ML; Malgras J; Drouet J; Amouch P
Rev Fr Transfus; 1974 Mar; 17(1):87-92. PubMed ID: 4212553
[No Abstract] [Full Text] [Related]
14. Purification and characterization of the serum ferroxidase inhibitor.
Calisch MP; Topham RW
Int J Biochem; 1984; 16(11):1127-34. PubMed ID: 6441732
[TBL] [Abstract][Full Text] [Related]
15. Round table discussion on plasma fractionation.
Vox Sang; 1972; 23(1):61-5. PubMed ID: 5081015
[No Abstract] [Full Text] [Related]
16. Hepatitis-free and stable human serum for intravenous therapy.
Stephan W
Vox Sang; 1971 May; 20(5):442-57. PubMed ID: 4106554
[No Abstract] [Full Text] [Related]
17. Hepatitis B antigen and prevention of post-transfusion hepatitis B.
Iwarson S; Hermodsson S; Lindholm A; Magnius L
Vox Sang; 1975; 28(4):278-84. PubMed ID: 804765
[TBL] [Abstract][Full Text] [Related]
18. [Australia antigen and transfusion hepatitis. A prospective study on the frequency and prevention of transfusion hepatitis].
Berthold H; Kleine N; Müller G
Zentralbl Bakteriol Orig A; 1972 May; 220(1):230-4. PubMed ID: 4145571
[No Abstract] [Full Text] [Related]
19. Plasma fractionation in the United States. A review for clinicians.
Ness PM; Pennington RM
JAMA; 1974 Oct; 230(2):247-50. PubMed ID: 4137885
[No Abstract] [Full Text] [Related]
20. C1q protein of human complement.
Calcott MA; Müller-Eberhard HJ
Biochemistry; 1972 Aug; 11(18):3443-50. PubMed ID: 4626765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
